Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
JAMA Oncology
|
December 23, 2020
Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma: Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial
Hans-Joachim Schmoll, Lars H Lindner, Peter Reichardt, et al.
Cancers
|
February 15, 2022
Characteristics and Outcome of Elderly Patients (>55 Years) with Acute Lymphoblastic Leukemia
Daniela V Wenge, Klaus Wethmar, Corinna A Klar, et al.
Plos One
|
August 31, 2016
Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction
Michele Pohlen, Nils H Thoennissen, Jan Braess, et al.
Blood Advances
|
April 25, 2022
Using stroma-anchoring cytokines to augment ADCC: a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse
Andrew F Berdel, Leo Ruhnke, Linus Angenendt, et al.
Plos One
|
January 3, 2018
Correction: Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction
Michele Pohlen, Nils H Thoennissen, Jan Braess, et al.
Cancers
|
June 11, 2020
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study
Christoph Schliemann, Mirjam Gerwing, Hauke Heinzow, et al.
Scientific Reports
|
February 19, 2026
Trabectedin plus CD13-targeted tissue factor tTF-NGR against advanced relapsed or refractory soft tissue sarcoma: translational data, clinical safety and efficacy
Kathrin Hessling, Caroline Brand, Christian Schwöppe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 14, 2021
Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study
Ivar Hompland, Stefano Ferrari, Stefan Bielack, et al.
Leukemia
|
June 12, 2019
The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia
Linus Angenendt, Eike Bormann, Caroline Pabst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2022
High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma
Raphael Koch, Hans Gelderblom, Lianne Haveman, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
JAMA Oncology
|
December 23, 2020
Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma: Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial
Hans-Joachim Schmoll, Lars H Lindner, Peter Reichardt, et al.
Cancers
|
February 15, 2022
Characteristics and Outcome of Elderly Patients (>55 Years) with Acute Lymphoblastic Leukemia
Daniela V Wenge, Klaus Wethmar, Corinna A Klar, et al.
Plos One
|
August 31, 2016
Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction
Michele Pohlen, Nils H Thoennissen, Jan Braess, et al.
Blood Advances
|
April 25, 2022
Using stroma-anchoring cytokines to augment ADCC: a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse
Andrew F Berdel, Leo Ruhnke, Linus Angenendt, et al.
Plos One
|
January 3, 2018
Correction: Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction
Michele Pohlen, Nils H Thoennissen, Jan Braess, et al.
Cancers
|
June 11, 2020
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study
Christoph Schliemann, Mirjam Gerwing, Hauke Heinzow, et al.
Scientific Reports
|
February 19, 2026
Trabectedin plus CD13-targeted tissue factor tTF-NGR against advanced relapsed or refractory soft tissue sarcoma: translational data, clinical safety and efficacy
Kathrin Hessling, Caroline Brand, Christian Schwöppe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 14, 2021
Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study
Ivar Hompland, Stefano Ferrari, Stefan Bielack, et al.
Leukemia
|
June 12, 2019
The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia
Linus Angenendt, Eike Bormann, Caroline Pabst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2022
High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma
Raphael Koch, Hans Gelderblom, Lianne Haveman, et al.
Page
of 8